Keep it cool Sir — India is no stranger to heat. Naturally, it has a long history, public memory and practices for dealing with it too. Some of those traditional practices to adapt to hea...

Bharat Biotech has sought permission from India's drug regulator to conduct a phase 2/3 study of its Covid vaccine Covaxin as a booster dose among those aged two to 18 years, sources told PTI. Pr...

Dr Reddy' Laboratories on Monday said the Drugs Controller General of India (DCGI) has granted approval to the single-shot Sputnik Light vaccine for restricted use in emergency situation in India....

Contradictory advice from two wings of the health ministry on whether the antiviral drug molnupiravir should be prescribed to Covid-19 patients could leave doctors and patients befuddled, medical expe...

Homegrown pharma majors Sun Pharma, Cipla, Hetero and Torrent on Tuesday announced plans to market their versions of antiviral drug Molnupiravir to treat high-risk adult patients with COVID-19 across ...

Bharat Biotech has sought the Drug Controller General of India's approval to conduct phase-3 trials of its COVID-19 intranasal vaccine (BBV154) to use as booster dose, sources said on Monday. The...

Biological E has received approval for conducting phase II/III human clinical trial of Covid-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology...

Hopeful moment Sir — The Drug Controller General of India’s approval for ZyCoV-D, the three-dose DNA vaccine manufactured by Zydus Cadila, comes as a relief for parents. Children aged 12 ...

Indigenously developed Zydus Cadila COVID-19 vaccine ZyCoV-D has received approval for Emergency Use Authorisation from the Drug Controller General of India and it will be administered to people 12 ye...

The first nasal vaccine against COVID-19, developed by Bharat Biotech, has received regulator's nod for conducting phase 2 and 3 clinical trials, the Department of Biotechnology said on Friday. P...